Challenges and Opportunities in Biotech PR
Industry experts in biotechnology PR share their advice on communicating in a highly regulated and technical environment
They must adhere to stringent regulatory and compliance policies. Plus, the information they’re working with is highly technical so it needs to be communicated with the highest level of precision and accuracy, all while maintaining a tone that reflects the fact that biotech stories often involve potential solutions to life-or-death situations.
In this whitepaper, our panel of experts discuss the essentials of biotech communications.
 |
Eric Endicott Senior Director of External Communications Illumina, Inc. |
 |
Kari Watson Co-founder and Managing Partner MacDougall |
 |
Liz Wolffe Head of Investor Relations and Corporate Communications Synlogic, Inc. |
